Author

M. Draminski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:chromatin & epigenetic regulation· 2 Assay:DNA methylation· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Assay:ChIP-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

B. Gielniewski· 2 shared B. Kaminska· 2 shared B. Wojtas· 2 shared K. Stepniak· 2 shared M. J. Dabrowski· 2 shared M. Jardanowska· 2 shared A. Dziedzic· 1 shared A. Macioszek· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Gielniewski

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Comprehensive analysis of the transcription factor REST regulatory networks in IDH-mutant and IDH-wild type glioma

M. Perycz, M. J. Dabrowski, M. Jardanowska, A.-J. Roura, B. Gielniewski, K. Stepniak, M. Draminski, B. Kaminska, B. Wojtas

This study identifies differences in REST regulatory networks between IDH-mutant and IDH-wild type gliomas, highlighting distinct gene expression control mechanisms.

bioRxiv · Jul 28, 2022 · PreprintCancer Biology

Mapping chromatin accessibility and active regulatory elements reveals new pathological mechanisms in human gliomas

K. Stepniak, M. A. Machnicka, J. Mieczkowski, A. Macioszek, B. Wojtas, B. Gielniewski, S. K. Krol, R. Guzik, M. J. Dabrowski, M. Draminski, M. Jardanowska, I. Grabowicz, A. Dziedzic, H. Kranas, K. Sienkiewicz, , B. Wilczynski

The paper maps chromatin accessibility and regulatory elements in human gliomas to identify new epigenetic mechanisms driving cancer progression.

bioRxiv · Mar 20, 2020Cancer Biology